# CTRB2

## Overview
The CTRB2 gene encodes chymotrypsinogen B2, a precursor to the serine protease enzyme chymotrypsin, which is integral to the digestive process. This gene is primarily expressed in pancreatic acinar cells, where it is secreted into the digestive tract and activated by trypsin into its functional form, chymotrypsin. Chymotrypsinogen B2 plays a pivotal role in protein digestion by breaking down dietary proteins into peptides, thus facilitating nutrient absorption (Bodas2024A). Additionally, CTRB2 is involved in the degradation of trypsinogen, preventing its premature activation and thereby protecting pancreatic tissue from damage (Rosendahl2017Genomewide). Genetic variations in CTRB2 have been linked to pancreatic diseases, including chronic pancreatitis and pancreatic ductal adenocarcinoma, highlighting its clinical significance (Bodas2024A; Rosendahl2017Genomewide).

## Function
The CTRB2 gene encodes chymotrypsinogen B2, a precursor to the enzyme chymotrypsin, which plays a crucial role in the digestive process. In healthy human cells, chymotrypsinogen B2 is produced by pancreatic acinar cells and secreted into the digestive tract, where it is activated into chymotrypsin. This enzyme functions as a serine protease, breaking down dietary proteins into smaller peptides, facilitating nutrient absorption and maintaining digestive health (Bodas2024A).

Chymotrypsinogen B2 is involved in the degradation of trypsinogen, a precursor to trypsin, another important digestive enzyme. This degradation process is essential for preventing the premature activation of trypsinogen, which could otherwise lead to pancreatic damage (Rosendahl2017Genomewide). The CTRB2 gene, along with its closely related counterpart CTRB1, contributes to the protective degradation of anionic trypsinogen (PRSS2), thereby playing a significant role in maintaining pancreatic function and preventing conditions such as chronic pancreatitis (Seltsam2020Sequencing).

The proper folding and function of chymotrypsinogen B2 are critical for normal pancreatic activity, and misfolding can lead to endoplasmic reticulum stress and inflammation, which are associated with pancreatic diseases (Bodas2024A).

## Clinical Significance
Mutations and alterations in the CTRB2 gene have been associated with several pancreatic diseases. A genome-wide association study identified a 16.6 kb inversion in the CTRB1-CTRB2 locus, which is linked to an increased risk of both alcoholic and non-alcoholic chronic pancreatitis (CP). This inversion affects the expression of CTRB1 and CTRB2, altering chymotrypsin activity and influencing trypsinogen degradation, a key factor in CP pathogenesis (Rosendahl2017Genomewide).

A common exon 6 deletion variant in CTRB2 has been linked to an increased risk of pancreatic ductal adenocarcinoma (PDAC). This deletion causes misfolding of the CTRB2 protein, leading to endoplasmic reticulum (ER) stress and inflammation. Mouse models mimicking this variant show increased sensitivity to pancreatic damage and impaired recovery from pancreatitis, suggesting a role in PDAC pathogenesis (Bodas2024A).

The CTRB1-CTRB2 inversion is also noted for its protective role in trypsinogen degradation, which can decrease CP risk. However, in certain populations, such as in China, the inverted allele is nearly fixed, indicating it may not contribute to CP risk there (Mayerle2019Genetics).

## Interactions
CTRB2 (chymotrypsinogen B2) is a serine protease precursor that plays a significant role in protein digestion. It is primarily activated in the small intestine through its interaction with trypsin, another digestive enzyme. Trypsin cleaves specific peptide bonds in CTRB2, converting it into its active form, chymotrypsin. This activation is a critical step in the digestive process, as it allows chymotrypsin to participate in the breakdown of dietary proteins into smaller peptides and amino acids, facilitating their absorption in the intestine.

The interaction between CTRB2 and trypsin is an example of a transitory activating interaction, where the precursor form of the enzyme is converted into its active state. This interaction underscores the importance of enzyme cascades in digestive processes, where the activation of one enzyme leads to the activation of others, ensuring efficient protein digestion. The precise regulation of these interactions is essential for maintaining digestive health and preventing premature activation of digestive enzymes, which could lead to tissue damage. The interplay between CTRB2 and trypsin highlights the complex network of proteolytic enzymes working in concert to achieve effective protein digestion.


## References


1. (Bodas2024A) A common CTRB misfolding variant associated with pancreatic cancer risk causes ER stress and inflammation in mice. This article has 0 citations.

[2. (Rosendahl2017Genomewide) Jonas Rosendahl, Holger Kirsten, Eszter Hegyi, Peter Kovacs, Frank Ulrich Weiss, Helmut Laumen, Peter Lichtner, Claudia Ruffert, Jian-Min Chen, Emmanuelle Masson, Sebastian Beer, Constantin Zimmer, Katharina Seltsam, Hana Algül, Florence Bühler, Marco J Bruno, Peter Bugert, Ralph Burkhardt, Giulia Martina Cavestro, Halina Cichoz-Lach, Antoni Farré, Josef Frank, Giovanni Gambaro, Sebastian Gimpfl, Harald Grallert, Heidi Griesmann, Robert Grützmann, Claus Hellerbrand, Péter Hegyi, Marcus Hollenbach, Sevastitia Iordache, Grazyna Jurkowska, Volker Keim, Falk Kiefer, Sebastian Krug, Olfert Landt, Milena Di Leo, Markus M Lerch, Philippe Lévy, Markus Löffler, Matthias Löhr, Maren Ludwig, Milan Macek, Nuria Malats, Ewa Malecka-Panas, Giovanni Malerba, Karl Mann, Julia Mayerle, Sonja Mohr, Rene H M te Morsche, Marie Motyka, Sebastian Mueller, Thomas Müller, Markus M Nöthen, Sergio Pedrazzoli, Stephen P Pereira, Annette Peters, Roland Pfützer, Francisco X Real, Vinciane Rebours, Monika Ridinger, Marcella Rietschel, Eva Rösmann, Adrian Saftoiu, Alexander Schneider, Hans-Ulrich Schulz, Nicole Soranzo, Michael Soyka, Peter Simon, James Skipworth, Felix Stickel, Konstantin Strauch, Michael Stumvoll, Pier Alberto Testoni, Anke Tönjes, Lena Werner, Jens Werner, Norbert Wodarz, Martin Ziegler, Atsushi Masamune, Joachim Mössner, Claude Férec, Patrick Michl, Joost P H Drenth, Heiko Witt, Markus Scholz, and Miklós Sahin-Tóth. Genome-wide association study identifies inversion in the ctrb1-ctrb2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. Gut, 67(10):1855–1863, July 2017. URL: http://dx.doi.org/10.1136/gutjnl-2017-314454, doi:10.1136/gutjnl-2017-314454. This article has 93 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2017-314454)

[3. (Seltsam2020Sequencing) Katharina Seltsam, Carola Pentner, Franziska Weigl, Stella Sutedjo, Constantin Zimmer, Sebastian Beer, Peter Bugert, Maren Ewers, Claudia Ruffert, Patrick Michl, Helmut Laumen, Heiko Witt, and Jonas Rosendahl. Sequencing of the complex ctrb1-ctrb2 locus in chronic pancreatitis. Pancreatology, 20(8):1598–1603, December 2020. URL: http://dx.doi.org/10.1016/j.pan.2020.09.017, doi:10.1016/j.pan.2020.09.017. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pan.2020.09.017)

[4. (Mayerle2019Genetics) Julia Mayerle, Matthias Sendler, Eszter Hegyi, Georg Beyer, Markus M. Lerch, and Miklós Sahin-Tóth. Genetics, cell biology, and pathophysiology of pancreatitis. Gastroenterology, 156(7):1951-1968.e1, May 2019. URL: http://dx.doi.org/10.1053/j.gastro.2018.11.081, doi:10.1053/j.gastro.2018.11.081. This article has 205 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2018.11.081)